---
title: 2. Class members and licensed uses
---

import Expander from "../../../src/components/Expander"

### Consult the summary of product characteristics for details of authorised indications of each SSRI.

### SSRIs: Approved names, common proprietary names and licensed indications

<table>
  <tr>
    <th></th>
    <th>
      <p>Citalopram</p>
    </th>
    <th>
      <p>
        Escital-opram
        <br />
        (enantiomer
        <sup>
          <a class="footnote-ref" href="#fn-1">
            1
          </a>
        </sup>
        of citalopram)
      </p>
    </th>
    <th>
      <p>
        <strong>Fluoxetine</strong>
      </p>
    </th>
    <th>
      <p>
        <strong>Fluvoxamine</strong>
      </p>
    </th>
    <th>
      <p>
        <strong>Paroxetine</strong>
      </p>
    </th>
    <th>
      <p>
        <strong>Sertraline</strong>
      </p>
    </th>
  </tr>
  <tr>
    <td>
      <p>Common proprietory names</p>
    </td>
    <td>
      <p>Cipramil</p>
    </td>
    <td>
      <p>Cipralex</p>
    </td>
    <td>
      <p>Prozac</p>
    </td>
    <td>
      <p>Faverin</p>
    </td>
    <td>
      <p>Seroxat</p>
    </td>
    <td>
      <p>Lustral</p>
    </td>
  </tr>
  <tr>
    <td>
      <p>
        Depressive illness
        <sup>
          <a class="footnote-ref" href="#fn-2">
            2
          </a>
        </sup>
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
  </tr>
  <tr>
    <td>
      <p>Generalised anxiety disorder</p>
    </td>
    <td></td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td></td>
    <td></td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td></td>
  </tr>
  <tr>
    <td>
      <p>Obsessive–compulsive disorder</p>
    </td>
    <td></td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
  </tr>
  <tr>
    <td>
      <p>
        Panic disorder with or without agoraphobia
        <sup>
          <a class="footnote-ref" href="#fn-3">
            3
          </a>
        </sup>
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td></td>
    <td></td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
  </tr>
  <tr>
    <td>
      <p>Social anxiety disorder (social phobia)</p>
    </td>
    <td></td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td></td>
    <td></td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
  </tr>
  <tr>
    <td>
      <p>Post-traumatic stress disorder</p>
    </td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
  </tr>
  <tr>
    <td>
      <p>Bulimia nervosa</p>
    </td>
    <td></td>
    <td></td>
    <td>
      <p>
        <img alt="Tickbox" src="../../assets/con126283.jpg" />
      </p>
    </td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
</table>

<div class="collected-footnotes">
  <sup>
    <a class="footnote-ref" href="#fn-1">
      1
    </a>
  </sup>
  <sup>
    <a class="footnote-ref" href="#fn-2">
      2
    </a>
  </sup>
  <sup>
    <a class="footnote-ref" href="#fn-3">
      3
    </a>
  </sup>
</div>

Antidepressants in other classes may also inhibit reuptake of serotonin, but only SSRIs are discussed here.

Only the following SSRIs are licensed for children and adolescents:

- Fluoxetine for the treatment of moderate to severe major depressive episode (in combination with psychological therapy) in children aged over eight years and adolescents
- Fluvoxamine for the treatment of obsessive–compulsive disorder in children aged over eight years and adolescents
- Sertraline for the treatment of obsessive–compulsive disorder in children aged over six years and adolescents.

[^1]: An enantiomer is one of a pair of chemical molecules with identical molecular formula, but one enantiomer cannot be superimposed on the other because it is a mirror image of the other. Often one enantiomer exerts considerably more biological activity than the other.
[^2]: A psychiatric disorder characterised by lowered mood, reduced energy and decreased activity. The severity of a depressive episode is divided clinically into mild, moderate and severe subtypes (the latter may or may not have psychotic features). Repeated episodes of depression, without a history of mania, are classified as recurrent depressive disorder.
[^3]: Abnormal fear or anxiety induced by being in crowds or in open spaces—environments which seem difficult to escape from or obtain help.
